AG
SNTI icon

Artal Group’s Senti Biosciences Holdings SNTI Stock Holding History

Artal Group’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,556
Closed -$37K – 124
2023
Q4 		$37K Hold
5,556
– – ﹤0.01% 95
2023
Q3 		$23K Hold
5,556
– – ﹤0.01% 102
2023
Q2 		$35K Hold
5,556
– – ﹤0.01% 116
2023
Q1 		$66K Hold
5,556
– – ﹤0.01% 116
2022
Q4 		$78K Sell
5,556
-100,000
-95% -$2.44M ﹤0.01% 129
2022
Q3 		$2.29M Hold
105,556
– – 0.1% 88
2022
Q2 		$2.07M Buy
105,556
+55,556
+111% +$4.46M 0.11% 93
2022
Q1 		$4.93M Hold
50,000
– – 0.21% 79
2021
Q4 		$4.93M Hold
50,000
– – 0.13% 105
2021
Q3 		$4.97M Hold
50,000
– – 0.11% 114
2021
Q2 		$4.97M Buy
+50,000
New +$4.99M 0.1% 118

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group's SNTI Position: Q1 2024 in Review

Artal Group sold out of Senti Biosciences Holdings (SNTI) in Q1 2024, closing a stake of 5,556 shares — an estimated $37K sold.

Artal Group first reported a position in SNTI in Q2 2021 and held it in 11 quarters. The position peaked at $4.97M in Q3 2021. 27 funds tracked by Wall St. Rank hold SNTI as of Q1 2024.

  • Artal Group reported no remaining Senti Biosciences Holdings position as of Q1 2024 after selling out during the quarter.
  • Artal Group sold 5,556 Senti Biosciences Holdings shares in Q1 2024, an estimated $37K.
  • Artal Group first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 11 quarters.
  • Artal Group's Senti Biosciences Holdings position peaked at $4.97M in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2024.

Based on Artal Group's 13F filing for Q1 2024, filed 13 May 2024.